Sanofi SA 2Q 2014-- Forecast

FRANKFURT--The following is a summary of analysts' forecasts for Sanofi SA (SNY) second-quarter results, based on a poll of seven analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released July 31.

=== 
                    Net      Business    Business   Business 
2nd Quarter       sales  Oper. Income  net income        EPS 
AVERAGE           8,047         2,067       1,473       1.12 
Prev. Year        8,003         2,017       1,475       1.11 
+/- in %           +0.5          +2.5        -0.2       +1.3 
 
MEDIAN            8,025         2,062       1,470       1.12 
Maximum           8,178         2,214       1,567       1.18 
Minimum           7,967         1,845       1,335       1.02 
Amount                7             7           7          7 
 
Bernstein         8,120         2,062       1,470       1.12 
Cowen and Company 7,970         1,845       1,335       1.02 
Deutsche Bank     7,991         2,160       1,513       1.18 
Exane BNP Paribas 7,967         2,022       1,455       1.11 
Helvea            8,178         2,214       1,567       1.18 
J.P. Morgan       8,076         2,130       1,505       1.15 
Morgan Stanley    8,025         2,037       1,463       1.11 
 
 
               Target price  Rating                DPS 2014 
 
AVERAGE               84.40  positive 3    AVERAGE     2.91 
Prev. Quarter         85.25  neutral  2    Prev. Year  2.80 
+/- in %               -1.0  negative 0    +/- in %    +3.8 
 
MEDIAN                82.00                MEDIAN      2.94 
Maximum               90.00                Maximum     2.95 
Minimum               81.00                Minimum     2.83 
Amount                    5                Amount         3 
 
Cowen and Company        --  Market perform              -- 
Deutsche Bank         87.00  Buy                       2.95 
Exane BNP Paribas     82.00  --                        2.94 
Helvea                82.00  Buy                         -- 
J.P. Morgan           81.00  Neutral                     -- 
Morgan Stanley        90.00  Overweight                2.83 
=== 

Year-earlier figures are as reported by the company.

DJG/voi 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires